Qatar National Research Fund (QNRF), in collaboration with Qatar Genome Programme (QGP), has launched the second cycle of the Path Towards Personalized Medicine (PPM) call, designed to support and advance research focused on providing medical treatment tailored to a patient’s individual characteristics.
Building on the success of the PPM’s first cycle, QNRF, part of Qatar Foundation Research and Development (QF R&D), hosted a presentation on the second cycle on February 9, aimed at benefiting from the valuable pilot-phase samples and data collated by Qatar Biobank (QBB), a member of QF and the QGP.
The personalised medical treatment that the PPM is designed to support is based on a patient’s genetic profile, with the goal of improving quality of care while reducing unnecessary diagnostic testing and therapies. The call also aims to support research into the correlation between disease phenotype and genotype.
